Supplement companies often claim peptides can amplify muscle gain and facilitate fat loss. But few studies have explored the impact of peptides on bodybuilding, and some are banned in professional ...

PDUFA target action date of June 30, 2026 for veligrotug for thyroid eye disease (TED); U.S. commercial preparations on track to support anticipated launch -- Marketing Authorization Application (MAA) ...

Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune disease, often accompanied by osteoporosis (OP), a serious complication that ...

Evaluating peptides for muscle growth requires examining multiple factors: product quality, scientific evidence, safety considerations, and realistic cost-benefit ratios. Quality varies dramatically ...

Do you ever finish a workout feeling beat up instead of energized? You're not alone. Here's something that surprised me when I first started using infrared saunas back in 2012: a single 30-minute ...

Scientists have made a breakthrough that could lead to effective treatments for lymphedema, a painful swelling condition for which there is currently no cure. Lymphedema can be congenital or caused by ...

If you're looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) ...

Our findings suggest that GLP-1 therapy holds real promise. While a randomized trial is still needed, the fact that many patients with IIH already qualify for GLP-1s due to diabetes or obesity means ...

GLP-1 medications can be effective for weight loss and diabetes management but require lifestyle changes and can have severe ...

Single this Valentine’s Day? You’re not alone. New research from The Harris Poll shows that nearly half of Americans (46%) are not in relationships—many of them on purpose. The report, shared ...

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, ...

Sarah Marriott, who lives with Type 1 diabetes, argues that research must ensure equal access to new technologies.